Tokyo, Japan

Rational Drug Design Laboratories

Calculating rank
USPTO Granted Patents = 6

% Expired Patents = 16.7


Forward Citations = 27

Loading Chart...
Loading Chart...

27 inventors (with patents filed for the assignee):

goldMedal Wataru Hamaguchi (3 out of 11 patents)

silverMedal Toru Kontani (3 out of 6 patents)

bronzeMedal Kenji Sudo (3 out of 3 patents)

4.  Junji Miyata (3 out of 7 patents)

5.  Hiroshi Suzuki (3 out of 9 patents)

6.  Akio Kamikawa (2 out of 14 patents)

7.  Tomoaki Kawano (2 out of 4 patents)

8.  Shiro Shigeta (2 out of 8 patents)

9.  Tomoyuki Yokota (2 out of 2 patents)

10.  Teruhiko Ide (1 out of 15 patents)

11.  Masanori Baba (1 out of 37 patents)

12.  Hiromitsu Takayama (1 out of 6 patents)

13.  Eiichi Nakai (1 out of 5 patents)

14.  Yoji Miyazaki (1 out of 2 patents)

15.  Hiroyuki Watanabe (1 out of 105 patents)


6 patents:

Company Overview
Rational Drug Design Laboratories is a research-focused biotechnology company specializing in computational drug design. Our team of experts use cutting-edge technology and algorithms to predict the most effective compounds for specific diseases, reducing the time and cost of traditional drug development. We collaborate with pharmaceutical companies and academic institutions to accelerate the discovery of new treatments and improve patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#2,469 in Tokyo

#5,990 in Japan

Tokyo, JP
Tokyo, Japan
Forward Citations = 27

27 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Rational Drug Design Laboratories. Retrieved from https://idiyas.com/company/rational-drug-design-laboratories

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…